Most Popular Articles : Pharmacogenetics and Genomics

Secondary Logo

Journal Logo

Most Popular Articles

ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19

Möhlendick, Birte; Schönfelder, Kristina; Breuckmann, Katharina; More

Pharmacogenetics and Genomics. 31(8):165-171, October 2021.

Implementation of upfront DPYD genotyping with a low-cost and high-throughput assay to guide fluoropyrimidine treatment in cancer patients

Pinheiro, Manuela; Peixoto, Ana; Rocha, Patrícia; More

Pharmacogenetics and Genomics. 33(8):165-171, October 2023.

Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis

Agyemang, Nana; Scarsi, Kimberly K.; Baker, Paxton; More

Pharmacogenetics and Genomics. 33(6):126-135, August 2023.

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions

Hung, Shuen-Iu; Chung, Wen-Hung; Jee, Shiou-Hwa; More

Pharmacogenetics and Genomics. 16(4):297-306, April 2006.

Exploratory analysis of 1936 SNPs in ADME genes for association with busulfan clearance in adult hematopoietic stem cell recipients

ten Brink, Marloes H.; Swen, Jesse J.; Böhringer, Stefan; More

Pharmacogenetics and Genomics. 23(12):675-683, December 2013.

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

Takahashi, Harumi; Wilkinson, Grant R.; Nutescu, Edith A.; More

Pharmacogenetics and Genomics. 16(2):101-110, February 2006.

Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

Tassaneeyakul, Wichittra; Jantararoungtong, Thawinee; Chen, Pei; More

Pharmacogenetics and Genomics. 19(9):704-709, September 2009.

Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci

Sucheston-Campbell, Lara E.; Clay-Gilmour, Alyssa I.; Barlow, William E.; More

Pharmacogenetics and Genomics. 28(2):49-55, February 2018.

The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response

Lewis, Joshua P.; Horenstein, Richard B.; Ryan, Kathleen; More

Pharmacogenetics and Genomics. 23(1):1-8, January 2013.

Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression

Benito, Rocío; Lumbreras, Eva; Abáigar, María; More

Pharmacogenetics and Genomics. 22(5):381-388, May 2012.

A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

Lonjou, Christine; Borot, Nicolas; Sekula, Peggy; More

Pharmacogenetics and Genomics. 18(2):99-107, February 2008.

Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population

Saksit, Niwat; Tassaneeyakul, Wichittra; Nakkam, Nontaya; More

Pharmacogenetics and Genomics. 27(7):255-263, July 2017.

PharmGKB summary: ibuprofen pathways

Mazaleuskaya, Liudmila L.; Theken, Katherine N.; Gong, Li; More

Pharmacogenetics and Genomics. 25(2):96-106, February 2015.

Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry

Mbavha, Bianza T.; Kanji, Comfort R.; Stadler, Nadina; More

Pharmacogenetics and Genomics. 32(5):173-182, July 2022.

The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia

Gutierrez-Camino, Angela; Oosterom, Natanja; den Hoed, Marissa A.H.; More

Pharmacogenetics and Genomics. 27(8):303-306, August 2017.

Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4)

Urban, Thomas J.; Yang, Chen; Lagpacan, Leah L.; More

Pharmacogenetics and Genomics. 17(9):773-782, September 2007.

Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia

Lopez-Lopez, Elixabet; Ballesteros, Javier; Piñan, Maria A.; More

Pharmacogenetics and Genomics. 23(2):53-61, February 2013.

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28

Minami, Hironobu; Sai, Kimie; Saeki, Mayumi; More

Pharmacogenetics and Genomics. 17(7):497-504, July 2007.

Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions

Kongpan, Thachanan; Mahasirimongkol, Surakameth; Konyoung, Parinya; More

Pharmacogenetics and Genomics. 25(8):402-411, August 2015.

Clopidogrel pathway

Sangkuhl, Katrin; Klein, Teri E.; Altman, Russ B.

Pharmacogenetics and Genomics. 20(7):463-465, July 2010.

Influence of the HER2 Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients: a meta-analysis

Gómez Peña, Celia; Dávila-Fajardo, Cristina L.; Martínez-González, Luis J.; More

Pharmacogenetics and Genomics. 25(8):388-393, August 2015.

Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice

Sychev, Dmitry Alekseevitch; Sokolov, Aleksey Vladimirovich; Reshetko, Olga Vilorovna; More

Pharmacogenetics and Genomics. 32(9):301-307, December 2022.

A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration

Lorés-Motta, Laura; van Asten, Freekje; Muether, Philipp S.; More

Pharmacogenetics and Genomics. 26(1):20-27, January 2016.

NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis

Suvichapanich, Supharat; Fukunaga, Koya; Zahroh, Hilyatuz; More

Pharmacogenetics and Genomics. 28(7):167-176, July 2018.

Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients

Tarasova, Linda; Kalnina, Ineta; Geldnere, Kristine; More

Pharmacogenetics and Genomics. 22(9):659-666, September 2012.

Mouse nerve growth factor suppresses neuronal apoptosis in valproic acid-induced autism spectrum disorder rats by regulating the phosphoinositide-3-kinase/serine/threonine kinase signaling pathway

Jian, Jie; Li, Li-Guo; Zhao, Peng-Ju; More

Pharmacogenetics and Genomics. 33(5):101-110, July 2023.

Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population

Tempark, Therdpong; Satapornpong, Patompong; Rerknimitr, Pawinee; More

Pharmacogenetics and Genomics. 27(12):429-437, December 2017.

A polymorphism located at an ATG transcription start site of the heme oxygenase-2 gene is associated with classical Parkinson's disease

Ayuso, Pedro; Martínez, Carmen; Lorenzo-Betancor, Oswaldo; More

Pharmacogenetics and Genomics. 21(9):565-571, September 2011.

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria

St Jean, Pamela L.; Koh, Gavin C.K.W.; Breton, John J.; More

Pharmacogenetics and Genomics. 30(7):161-165, September 2020.

Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertension

Thomeas-McEwing, Vasiliki; Psotka, Mitchell A.; Gamazon, Eric R.; More

Pharmacogenetics and Genomics. 32(4):144-151, June 2022.